Literature DB >> 6771213

Involvement of bivalent cations and arachidonic acid in neutrophil aggregation.

J T O'Flaherty.   

Abstract

Chemotactic factors and arachidonic acid aggregate neutrophils; indomethacin and 5,8,11,14-eicosatetraynoic acid, two blockers of cellular arachidonate metabolism, inhibit these responses. Additionally, A23187, an ionophore which specifically transports bivalent cations into cells, also aggregates the neutrophils, and this response, as well as the response to chemotactic factors, requires the presence of extracellular calcium and magnesium. In this report these relationships were further studied. It was found that human neutrophil aggregation stimulated by arachidonic acid required calcium and magnesium. Furthermore, cells preincubated with arachidonate for 4 min before exposure to the bivalent cations did not aggregate before or after this exposure and, following this exposure, were refractory to subsequent stimulation by more arachidonate, a chemotactic tripeptide (formylmethionylleucylphenylalanine), or A23187, i.e., these cells had become nonselectively desensitized to the aggregating agents. Finally, indomethacin and 5,8,11,14-eicoasatetraynoic acid inhibited the aggregation response stimulated by A23187 and their potency in doing so paralleled their potency in inhibiting the responses induced by arachidonate or the chemotactic tripeptide. Thus, the neutrophil aggregation responses induced by arachidonate, chemotactic factor, and A23187 were similarly influenced by preincubating the cells with arachidonate, had similar requirements for calcium and magnesium, and were similarly inhibited by blockers of arachidonate metabolism. It appears that bivalent cations and arachidonic acid play essential and, perhaps, interacting roles in the aggregation response to diverse stimuli.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6771213     DOI: 10.1007/bf00914164

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  38 in total

1.  Indomethacin in submicromolar concentrations inhibits cyclic AMP-dependent protein kinase.

Authors:  H S Kantor; M Hampton
Journal:  Nature       Date:  1978 Dec 21-28       Impact factor: 49.962

2.  Arachidonic acid induced degranulation of rabbit peritoneal neutrophils.

Authors:  P H Naccache; H J Showell; E L Becker; R I Sha'afi
Journal:  Biochem Biophys Res Commun       Date:  1979-03-15       Impact factor: 3.575

3.  Stimulation of the release of prostaglandins from polymorphonuclear leukocytes by the calcium inophore A23187.

Authors:  B Wentzell; R M Epand
Journal:  FEBS Lett       Date:  1978-02-15       Impact factor: 4.124

4.  Effect of prostaglandin E 1 on leukocyte migration.

Authors:  G Kaley; R Weiner
Journal:  Nat New Biol       Date:  1971-11-24

5.  Drugs which inhibit prostaglandin biosynthesis.

Authors:  R J Flower
Journal:  Pharmacol Rev       Date:  1974-03       Impact factor: 25.468

6.  Lipids of alveolar macrophages, polymorphonuclear leukocytes, and their phagocytic vesicles.

Authors:  R J Mason; T P Stossel; M Vaughan
Journal:  J Clin Invest       Date:  1972-09       Impact factor: 14.808

7.  Substances which aggregate neutrophils. Mechanism of action.

Authors:  J T O'Flaherty; H J Showell; E L Becker; P A Ward
Journal:  Am J Pathol       Date:  1978-07       Impact factor: 4.307

8.  An enzymatic mechanism for the antithrombotic and antihemostatic actions of aspirin.

Authors:  A L Willis
Journal:  Science       Date:  1974-01-25       Impact factor: 47.728

9.  Release of prostaglandins from human polymorphonuclear leukocytes.

Authors:  R B Zurier; D M Sayadoff
Journal:  Inflammation       Date:  1975-03       Impact factor: 4.092

10.  Chemotactic activity of thromboxane B2, prostaglandins and their metabolites for polymorphonuclear leucocytes.

Authors:  E A Kitchen; J R Boot; W Dawson
Journal:  Prostaglandins       Date:  1978-08
View more
  6 in total

1.  Neutrophil aggregation during migration in vivo.

Authors:  G Egger; S Porta; D Gollmann
Journal:  Inflammation       Date:  1982-06       Impact factor: 4.092

2.  A rapid quantitative assay for activated neutrophils.

Authors:  W W Bullock; H R Creamer; W L Gabler
Journal:  Inflammation       Date:  1982-09       Impact factor: 4.092

3.  Neutrophil-aggregating activity of monohydroxyeicosatetraenoic acids.

Authors:  J T O'Flaherty; M J Thomas; C J Lees; C E McCall
Journal:  Am J Pathol       Date:  1981-07       Impact factor: 4.307

4.  Activated rat neutrophils. A sequential quantitative assay for aggregation and NBT reduction.

Authors:  K O Fennell; H R Creamer; W L Gabler; A C Brown; W W Bullock
Journal:  Inflammation       Date:  1984-09       Impact factor: 4.092

5.  1-O-Alkyl-sn-glyceryl-3-phosphorylcholines: a novel class of neutrophil stimulants.

Authors:  J T O'Flaherty; R L Wykle; C H Miller; J C Lewis; M Waite; D A Bass; C E McCall; L R DeChatelet
Journal:  Am J Pathol       Date:  1981-04       Impact factor: 4.307

Review 6.  Neutrophils in innate host defense against Staphylococcus aureus infections.

Authors:  Kevin M Rigby; Frank R DeLeo
Journal:  Semin Immunopathol       Date:  2011-11-12       Impact factor: 9.623

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.